11.08
-0.78(-6.58%)
Currency In USD
| Previous Close | 11.86 |
| Open | 11.95 |
| Day High | 11.95 |
| Day Low | 10.93 |
| 52-Week High | 37 |
| 52-Week Low | 9.81 |
| Volume | 97,047 |
| Average Volume | 135,086 |
| Market Cap | 153.93M |
| PE | 0 |
| EPS | 0 |
| Moving Average 50 Days | 13.04 |
| Moving Average 200 Days | 16.14 |
| Change | -0.78 |
If you invested $1000 in Crescent Biopharma, Inc. (CBIO) 10 years ago, it would be worth $84,124.21 as of January 03, 2026 at a share price of $11.08. Whereas If you bought $1000 worth of Crescent Biopharma, Inc. (CBIO) shares 5 years ago, it would be worth $42,137.29 as of January 03, 2026 at a share price of $11.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
GlobeNewswire Inc.
Dec 04, 2025 11:35 AM GMT
Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple antibody-drug conjugates (ADCs), generating clinical data in global markets and Greater China CR-001,
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
GlobeNewswire Inc.
Dec 04, 2025 11:30 AM GMT
Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China Collaboration designed to accelerate and expand the development of synergistic combinat
Crescent Biopharma Announces Grants of Inducement Awards
GlobeNewswire Inc.
Nov 17, 2025 9:15 PM GMT
WALTHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the